def14a
Table of Contents

SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(A)
OF THE SECURITIES EXCHANGE ACT OF 1934
FILED BY THE REGISTRANT þ
FILED BY A PARTY OTHER THAN THE REGISTRANT o
Check the appropriate box:
     
o
  Preliminary Proxy Statement
o
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
þ
  Definitive Proxy Statement
o
  Definitive Additional Materials
o
  Soliciting Material Pursuant to §240.14a-12
GENESIS MICROCHIP INC.
 
(Name of Registrant as Specified In Its Charter)
Not Applicable
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
PAYMENT OF FILING FEE (CHECK THE APPROPRIATE BOX):
                 
þ   No fee required.
o   Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
 
    1 )   Title of each class of securities to which transaction applies:    
 
               
 
    2 )   Aggregate number of securities to which transaction applies:    
 
               
 
    3 )   Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):    
 
               
 
    4 )   Proposed maximum aggregate value of transaction:    
 
               
 
    5 )   Total fee paid:    
 
               
o   Fee paid previously with preliminary materials.
 
               
o   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which
    the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or
    Schedule and the date of its filing.
 
    1 )   Amount Previously Paid:    
 
               
 
    2 )   Form, Schedule or Registration Statement No.:    
 
               
 
    3 )   Filing Party:    
 
               
 
    4 )   Date Filed:    

 


Table of Contents

Genesis Logo
Genesis Microchip Inc.
2150 Gold Street
Alviso, California 95002
(408) 262-6599
 
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON SEPTEMBER 13, 2005
 
To our Stockholders:
      We are holding our 2005 annual meeting of stockholders on Tuesday, September 13, 2005 at 10:00 a.m. Pacific Time. It will be held at our offices located at 180 Baytech Drive, Suite 110, San Jose, California 95134. Only stockholders of record on July 15, 2005 are entitled to notice of and to vote at our annual meeting or at any adjournment or postponement of it. The purpose of the meeting is:
        1. To elect two Class I directors, each to serve for a term of three years, expiring on the date of our 2008 annual meeting of stockholders or until a successor is elected;
 
        2. To ratify the appointment of independent accountants for fiscal 2006; and
 
        3. To transact any other business that may properly come before either the annual meeting or any adjournment or postponement of it.
      Your Board of Directors unanimously recommends that you vote to approve all of the proposals before you. Those proposals are described more fully in the accompanying proxy statement, which we urge you to read.
      Your vote is important. Whether or not you plan to attend the meeting in person, you are urged to ensure that your shares are represented at the annual meeting by following the instructions on the enclosed proxy card. Please refer to the proxy card for more information on how to submit your vote.
  By order of the Board of Directors,
 
  /s/ Ava M. Hahn
 
 
  Ava M. Hahn
  Secretary
July 28, 2005


TABLE OF CONTENTS

INTRODUCTION
QUESTIONS AND ANSWERS ABOUT THE PROXY MATERIALS AND THE ANNUAL MEETING
PROPOSAL 1 -- ELECTION OF DIRECTORS
PROPOSAL 2 -- APPOINTMENT OF INDEPENDENT ACCOUNTANTS
TRANSACTION OF OTHER BUSINESS
EQUITY COMPENSATION PLAN INFORMATION
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
COMPENSATION COMMITTEE’S REPORT ON EXECUTIVE COMPENSATION
STOCK PERFORMANCE GRAPH
AUDIT COMMITTEE REPORT
STOCKHOLDER PROPOSALS
CONTACTING THE BOARD OF DIRECTORS


Table of Contents

Genesis Microchip Inc.
2150 Gold Street
Alviso, California 95002
(408) 262-6599
 
PROXY STATEMENT
 
INTRODUCTION
      The accompanying proxy is solicited by the Board of Directors of Genesis Microchip Inc., a Delaware corporation (“we,” “us,” “Genesis” or the “Company”), for use at our 2005 annual meeting of stockholders to be held on Tuesday, September 13, 2005 at 10:00 a.m. Pacific Time, or any adjournment thereof, for the purposes set forth in this proxy statement and the accompanying Notice of Annual Meeting. The annual meeting will be held at our offices located at 180 Baytech Drive, Suite 110, San Jose, California 95134.
      These proxy solicitation materials will be mailed on or about August 12, 2005 to all stockholders entitled to vote at our annual meeting.
QUESTIONS AND ANSWERS ABOUT
THE PROXY MATERIALS AND THE ANNUAL MEETING
Why are you sending me this proxy statement?
      We are sending you this proxy statement and the enclosed proxy card because our Board of Directors is soliciting your proxy to vote at our annual meeting of stockholders. That meeting is scheduled to take place on Tuesday, September 13, 2005. This proxy statement summarizes information concerning the proposals to be voted on at that meeting. This information will help you to make an informed vote at the annual meeting.
What proposals will be voted on at the meeting?
      We have scheduled two proposals to be voted on at the meeting:
        1. The election of two Class I directors, each to serve for a term of three years expiring on the date of our 2008 annual meeting of stockholders or until a successor is elected; and
 
        2. The ratification of the appointment of independent accountants for fiscal 2006.
What is the voting recommendation?
      Your Board of Directors recommends that you vote your shares “FOR” the election of each of the nominees to the Board and “FOR” the other proposal.
Who is entitled to vote?
      Only stockholders of record of our common stock at the close of business on July 15, 2005 are entitled to notice of, and to vote at, our annual meeting. As of the close of business on the record date, there were 34,221,940 shares of our common stock outstanding and entitled to vote held by approximately 199 stockholders of record. Each stockholder is entitled to one vote for each share of common stock held as of the record date.


Table of Contents

What is the difference between holding shares as a stockholder of record and as a beneficial owner?
      Most stockholders hold their shares through a stockbroker, bank or other nominee rather than directly in their own name. As summarized below, there are some distinctions between shares held of record and those owned beneficially.
Stockholder of record
      If your shares are registered directly in your name with our transfer agent, Mellon Investor Services LLC, then you are considered to be the stockholder of record with respect to those shares, and we are sending these proxy materials directly to you. As the stockholder of record, you have the right to grant your voting proxy directly to us or to vote in person at the meeting. We have enclosed a proxy card for you to use.
Beneficial owner
      If your shares are held in a stock brokerage account or by a bank or other nominee, you are considered the beneficial owner of shares held in street name, and your broker or nominee is forwarding these proxy materials to you. Your broker or nominee is considered to be the stockholder of record with respect to those shares. As the beneficial owner, you have the right to direct your broker how to vote and are also invited to attend the meeting. However, since you are not the stockholder of record, you may not vote these shares in person at the meeting. Your broker or nominee has enclosed a voting instruction card for you to use in directing the broker or nominee how to vote your shares.
How can I vote my shares in person at the meeting?
      Shares held directly in your name as the stockholder of record may be voted in person at the annual meeting. If you choose to do so, please bring the enclosed proxy card or proof of identification.
      Even if you currently plan to attend the annual meeting, we recommend that you also submit your proxy as described below so that your vote will be counted if you later decide not to attend the meeting. You may vote shares held in street name in person only if you obtain a signed proxy from the record holder giving you the right to vote the shares.
How can I vote my shares without attending the meeting?
      Whether you hold shares directly as the stockholder of record or beneficially in street name, you may direct your vote without attending the meeting.
Stockholder of record
      You may vote by granting a proxy. Please refer to the summary voting instructions included on your proxy card. You may vote by mail by signing your proxy card and mailing it in the enclosed postage prepaid and addressed envelope. If you provide specific voting instructions, your shares will be voted as you instruct. If you sign the card but do not provide instructions, your shares will be voted as described below in “How are votes counted?”

2


Table of Contents

Beneficial owner
      For shares held in street name, refer to the voting instruction card included by your broker or nominee.
Can I change my vote after I submit my proxy?
      Yes. You can change your vote at any time before we vote your proxy at the annual meeting.
Stockholder of record
      If you are a stockholder of record you can change your vote by:
  •  Sending a written notice to our Secretary at our principal executive offices in Alviso, California stating that you would like to revoke your proxy,
 
  •  Completing a new proxy card and sending it to our Secretary. The new proxy card will automatically replace any earlier-dated proxy card that you returned, or
 
  •  Attending the annual meeting and voting in person.
      If you choose to revoke your proxy by attending the annual meeting, you must vote at the meeting in accordance with the rules for voting at the annual meeting. Attending the annual meeting will not, by itself, constitute revocation of your proxy.
Beneficial owner
      If you instructed a broker or nominee to vote your shares, follow your broker or nominee’s directions for changing those instructions.
How are votes counted?
      In the election of directors, you may vote “FOR” all of the nominees or your vote may be “WITHHELD” with respect to one or more of the nominees. For the other proposals, you may vote “FOR,” “AGAINST” or “ABSTAIN.” Shares may also be counted as broker non-votes. Generally, broker non-votes occur when shares held by a broker for a beneficial owner are not voted with respect to a particular proposal because the broker has not received voting instructions from the beneficial owner and the broker lacks discretionary voting power to vote such shares.
      The inspector of election appointed for the meeting, who will separately tabulate affirmative votes, negative votes, abstentions and broker non-votes, will tabulate all votes. Shares that are voted “FOR,” “AGAINST” or “WITHHELD” on a proposal will be treated as being present at the meeting for purposes of establishing a quorum. Shares that are voted “FOR” or “AGAINST” will also be treated as votes cast on the proposal. Shares that abstain from voting on a proposal, and shares held by a broker nominee in “street name” where the broker indicates on a proxy that it does not have discretionary authority to vote on the proposal, will be treated as shares that are present at the meeting for purposes of establishing a quorum, but will not be treated as votes cast on the proposal. Although not considered as votes cast, abstentions and broker non-votes may prevent a proposal from receiving the affirmative vote of a majority of the required quorum and, in that case, would have the same effect as votes against the proposal.
      If you sign your proxy card or broker voting instruction card with no further instructions, your shares will be voted in accordance with the recommendations of the Board (“FOR” all of our nominees to the Board, “FOR” all other items described in this proxy statement and in the discretion of the proxy holders on any other matters that properly come before the meeting).
What vote is required to approve each of the proposals?
      With respect to the proposal to elect two Class I directors, the two nominees receiving the greatest number of votes will be elected, even if the votes they receive are less than a majority of shares present and entitled to vote. Abstentions are not counted towards the tabulation of votes cast for the election of directors.

3


Table of Contents

      All other proposals require the affirmative “FOR” vote of a majority of those votes cast; that majority must also constitute at least a majority of the required quorum.
What does it mean if I receive more than one proxy or voting instruction card?
      It means your shares are registered differently or are in more than one account. Please provide voting instructions for each proxy and voting instruction card you receive.
Where can I find the voting results of the meeting?
      We will announce preliminary voting results at the annual meeting and publish final results in our quarterly report on Form 10-Q for the second quarter of fiscal year 2006, which ends September 30, 2005.
What happens if additional proposals are presented at the meeting?
      Other than the proposals described in this proxy statement, we do not expect any matters to be presented for a vote at the annual meeting. If you grant a proxy, the persons named as proxy holders will have the discretion to vote your shares on any additional matters properly presented for a vote at the meeting. If for any unforeseen reason any of our nominees is not available as a candidate for director, the persons named as proxy holders will vote your proxy for such other candidate(s) as may be nominated by the Board of Directors.
Must a minimum number of stockholders vote or be present at the annual meeting?
      A quorum of stockholders is necessary to hold a valid meeting. Our bylaws provide that a majority of all of the shares of our stock entitled to vote, whether present in person or represented by proxy, will constitute a quorum for the transaction of business at the annual meeting. Shares that are voted “FOR,” “AGAINST,” “WITHHELD” or “ABSTAIN” on any proposal, as well as broker non-votes, will be treated as being present and entitled to vote for purposes of establishing a quorum.
Is cumulative voting permitted for the election of directors?
      Stockholders may not cumulate votes in the election of directors.
Who will bear the cost of soliciting votes for the meeting?
      We will pay the entire cost of preparing, assembling, printing, mailing and distributing these proxy materials. If you choose to access the proxy materials and/or vote over the Internet, however, you are responsible for Internet access charges you may incur. In addition to the mailing of these proxy materials, the solicitation of proxies or votes may be made in person, by telephone or by electronic communication by our directors, officers and employees, who will not receive any additional compensation for such solicitation activities. We may also hire our transfer agent, Mellon Investor Services LLC, or another proxy solicitor to assist us in the distribution of proxy materials and the solicitation of votes. We will pay any proxy solicitor a reasonable and customary fee plus expenses for those services. We will also reimburse brokerage houses and other custodians, nominees and fiduciaries for their reasonable out-of-pocket expenses for forwarding proxy and solicitation materials to our beneficial stockholders.
PROPOSAL 1 — ELECTION OF DIRECTORS
      We have a classified Board of Directors, with overlapping terms of office. The term for the Class I directors expires at this 2005 annual meeting. The term for the Class II directors expires at the 2006 annual meeting and the term for the Class III directors expires at the 2007 annual meeting. Each director serves for a three-year term or until his successor is duly elected and qualified.
      The Board’s nominees for election by the stockholders as Class I directors are Tim Christoffersen and Robert H. Kidd. Our Nominating Committee has recommended and the Board has approved these nominations. Mr. Christoffersen is currently a member of our Audit Committee and Corporate Governance

4


Table of Contents

Committee. Mr. Kidd is a currently a member of our Audit Committee and our Nominating Committee. If elected, the two nominees will serve as directors until our 2008 annual meeting or until a successor is duly elected and qualified. If either of the nominees declines to serve, proxies may be voted for a substitute nominee as we may designate.
      If a quorum is present and voting, the two nominees for Class I directors receiving the highest number of votes “FOR” will be elected as the Class I directors. The persons named in the enclosed proxy intend to vote the shares represented by those proxies for the election of these two nominees.
Directors
      Currently, there are eight (8) members of the Board of Directors. However, Eric Erdman has decided to resign effective September 13, 2005, the date of our 2005 annual meeting of stockholders. Effective September 13, 2005, the number of authorized directors will be reduced to seven (7). The following sets forth certain information concerning our current directors as well as our Class I nominees to be elected at the 2005 annual meeting.
                     
            Director
Name   Age   Position   Since
             
Class I Nominees:
                   
Tim Christoffersen(1)(3)
    63     Director Nominee     2002  
Robert H. Kidd(1)(4)
    61     Director Nominee     2002  
Class II Directors Whose Terms Expire at the 2006 Annual Meeting:
                   
Eric Erdman(5)
    47     Director     2003  
Chandrashekar M. Reddy(3)
    45     Director     2002  
Elias Antoun
    48     Director     2004  
Class III Directors Whose Terms Expire at the 2007 Annual Meeting:
                   
Jon Castor(1)(4)
    53     Director     2004  
Chieh Chang(2)(3)
    53     Director     2004  
Jeffrey Diamond(2)(4)
    53     Chairman of the Board     2001  
 
(1)  Member of the Audit Committee.
 
(2)  Member of the Compensation Committee.
 
(3)  Member of the Corporate Governance Committee.
 
(4)  Member of the Nominating Committee.
 
(5)  Mr. Erdman has decided to resign effective September 13, 2005.
Nominees for Election to Class I Directorship Expiring at the 2008 Annual Meeting
      Tim Christoffersen was appointed as a Director in August 2002. Mr. Christoffersen has served as Chief Financial Officer of Monolithic Power Systems, Inc. (MPS), a semiconductor company, since June 2004, and served on MPS’s board of directors from March 2004 to July 2004. Since January 1999, Mr. Christoffersen has been a financial consultant to technology companies. Prior to that, Mr. Christoffersen served as Chief Financial Officer of NeoParadigm Labs, Inc. from 1998 to 1999 and as Chief Financial Officer of Chips & Technologies, Inc. from 1994 until its sale to Intel Corporation in 1998. Mr. Christoffersen was Executive Vice President, Director and Chief Operating Officer of Resonex, Inc. from 1991 to 1992. From 1986 to 1991, Mr. Christoffersen held several managerial positions with Ford Motor Company. Mr. Christoffersen is a Phi Beta Kappa graduate of Stanford University where he earned a B.A. in Economics. He also holds a Master’s degree in Divinity from Union Theological Seminary in New York City.

5


Table of Contents

      Robert H. Kidd was appointed as a Director in August 2002. Mr. Kidd serves as President of Location Research Company of Canada Limited, a consulting company. Mr. Kidd served as Chief Financial Officer of Technology Convergence Inc. from 2000 to 2002, of Lions Gate Entertainment Corp. from 1997 to 1998, and of InContext Systems Inc. from 1995 to 1996. He served as Senior Vice President, Chief Financial Officer and Director of George Weston Limited from 1981 to 1995, as a partner of Thome Riddell, Chartered Accountants, a predecessor firm of KPMG LLP, from 1973 to 1981 and as a Lecturer in Finance, Faculty of Management Studies, University of Toronto, from 1971 to 1981. Mr. Kidd has served on several professional committees, including the Toronto Stock Exchange Investors & Issuers Advisory Committee from 1993 to 1998, the Canadian Institute of Chartered Accountants Emerging Issues Committee from 1992 to 1997 and the Canadian Securities Administrators Committee on Conflicts of Interest in Underwriting from 1994 to 1996. He currently serves as a director of several private entities. Mr. Kidd has a B. Commerce from the University of Toronto and an M.B.A. from York University. Mr. Kidd is a Fellow of the Institute of Chartered Accountants of Ontario.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS
A VOTE “FOR” EACH DIRECTOR NOMINEE
Class II Directors Whose Terms Expire at the 2006 Annual Meeting
      Elias Antoun has served as President and Chief Executive Officer of the Company and a member of our Board of Directors since November 2004. Prior to his appointment, Mr. Antoun served as the President and Chief Executive Officer of Pixim, Inc., an imaging solution provider for the video surveillance market, between March 2004 and November 2004. From February 2000 to August 2003, Mr. Antoun served as the President and Chief Executive Officer of MediaQ, Inc., a mobile handheld graphics IC company acquired by NVIDIA Corporation in August 2003. From January 1991 to February 2000, Mr. Antoun held a variety of positions with LSI Logic Corporation, most recently serving as Executive Vice President of the Consumer Products Division from 1998 until his departure in January 2000. Mr. Antoun has served as a Director of HPL Technologies, Inc. since August 2000 and as Chairman of the Board of Directors of HPL Technologies, Inc. since July 2002.
      Eric Erdman became a Director in May 2003 and previously served as a Director from October 1995 to September 1996. Since April 2005, Mr. Erdman has served as Executive Vice President of Operations and Chief Financial Officer of Silicon Optix, Inc., a supplier of digital processing integrated circuits. From July 2003 to November 29, 2004, Mr. Erdman served as our Interim Chief Executive Officer. Mr. Erdman also served as our Chief Financial Officer from March 2002 to February 2004, and previously held the position from December 1997 to February 2002. Mr. Erdman also served as our Secretary from June 2002 to October 2003, and from October 1995 to February 2002. From March 2002 to June 2002, Mr. Erdman served as our Assistant Secretary. Mr. Erdman joined Genesis in July 1995 as Director, Finance and Administration and served as Vice President, Finance and Administration from July 1996 to May 1999. Mr. Erdman holds a Bachelor of Mathematics degree from the University of Waterloo, and he is a member of the American Institute of Certified Public Accountants and of the Canadian Institute of Chartered Accountants. As noted above, Mr. Erdman has decided to resign effective September 13, 2005.
      Chandrashekar M. Reddy joined Genesis as a director upon its acquisition of Sage, Inc. in February 2002. He served as Vice Chairman and as Executive Vice President, Engineering of Genesis from February 2002 to November 2002. He served as Chairman of the Board and Chief Executive Officer of Sage from its inception in 1994 until its acquisition by Genesis in February 2002. Mr. Reddy has been the Chief Executive Officer of Athena Semiconductors, Inc., a wireless communications business, since December 2002 and a member of its Board of Directors since January 2002. From 1986 to 1995, Mr. Reddy held several design and program management positions at Intel Corporation. Mr. Reddy received an M.S. in Electrical Engineering from the University of Wisconsin, Madison and a B.S. in Electrical Engineering from the Indian Institute of Technology.

6


Table of Contents

Class III Directors Whose Terms Expire at the 2007 Annual Meeting
      Jon Castor has been a director of Genesis since November 2004. From January 2004 to June 2004, Mr. Castor was an Executive Advisor to the Chief Executive Officer of Zoran Corporation, and from August 2003 to December 2003, he was Senior Vice President and General Manager of Zoran’s DTV Division. From October 2002 to August 2003, Mr. Castor was the Senior Vice President and General Manager of the Teralogic Group at Oak Technology Inc., a developer of integrated circuits (ICs) and software for digital televisions and printers which was acquired by Zoran. Prior to that, Mr. Castor co-founded Serologic, Inc., a developer of digital television ICs, software and systems in June 1996 where he served in several capacities including as its President, Chief Financial Officer and director from June 1996 to November 2000, and as its Chief Executive Officer and director from November 2000 to October 2002, when it was acquired by Oak Technology. Mr. Castor received his B.A. with distinction from Northwestern University and his M.B.A. from Stanford Graduate School of Business.
      Chieh Chang has been a director of Genesis since November 2004. Mr. Chang has been a member of the board of directors of Oplink Communications, Inc. since September 1995. Since February 2003, Mr. Chang has served as Vice Chairman of Programmable Microelectronics Company, Inc., a fabless semiconductor design company, and from February 2000 to February 2003, as its Chief Executive Officer. From April 1992 to August 1996, Mr. Chang was the Director of Technology at Cirrus Logic, Inc., a semiconductor company. Mr. Chang received his B.S. in Electrical Engineering from the National Taiwan University and his M.S. in Electrical Engineering from UCLA.
      Jeffrey Diamond was appointed Chairman of the Board in July 2003, and has served as a director since April 2001. After our acquisition of Paradise Electronics, Inc. in May 1999, Mr. Diamond also served as an executive officer and as a consultant to Genesis through December 2000. Prior to that, he served as a director of Paradise from its inception in 1996 and as its Chief Executive Officer from September 1998 until May 1999. Mr. Diamond held senior management positions at Cirrus Logic, Inc. from April 1992 to March 1995. Mr. Diamond received his B.S. in Business Administration from the University of Illinois.
The Board of Directors, its Committees and Meetings
      Board of Directors. The Board of Directors held 28 meetings during the fiscal year ended March 31, 2005. Each director attended or participated telephonically in 75% or more of the aggregate of (i) the total number of the meetings of the Board of Directors (held during the period for which such director was a director) and (ii) the total number of meetings of all committees on which such director served (held during the period for which such director served as a committee member) during the fiscal year ended March 31, 2005.
      The Board of Directors has determined that each of its current directors, including all nominee directors, except Elias Antoun, Eric Erdman and Chandrashekar Reddy, has no material relationship with Genesis and is independent within the meaning of the NASDAQ Stock Market, Inc. director independence standards, as currently in effect.
      Our Board of Directors has standing Compensation, Audit, Corporate Governance and Nominating Committees.
      Compensation Committee. The Compensation Committee reviews and evaluates the compensation and benefits of our officers, reviews general policy matters relating to compensation and benefits of our employees and makes recommendations concerning these matters to the Board of Directors. The Compensation Committee also administers our stock option plans and stock purchase plan. The Compensation Committee held seven meetings during the fiscal year ended March 31, 2005.
      Currently, our Compensation Committee consists of Mr. Diamond and Mr. Chang each of whom qualifies as “independent” in accordance with the published listing requirements of Nasdaq. Mr. Diamond serves as chairman of this committee.

7


Table of Contents

      Audit Committee. Among other things, the Audit Committee reviews the scope and timing of audit services and any other services that our independent accountants are asked to perform, the auditors’ report on our consolidated financial statements following completion of their audit and our policies and procedures with respect to internal accounting and financial controls.
      Currently, our Audit Committee consists of Mr. Christoffersen, Mr. Castor and Mr. Kidd. Mr. Kidd serves as chairman of this committee. The Audit Committee held eleven meetings during the fiscal year ended March 31, 2005. In addition to qualifying as “independent” in accordance with the published listing requirements of Nasdaq, each member of the Audit Committee qualifies as “independent” under special standards established by the SEC for members of audit committees. The Audit Committee also includes at least one independent member who is determined by the Board to meet the qualifications of an “audit committee financial expert” in accordance with SEC rules, including that the person meets the relevant definition of an independent director. Each of the current Audit Committee members has been determined to be an independent director and an audit committee financial expert. Stockholders should understand that this designation is a disclosure requirement of the SEC related to the Audit Committee members’ experience and understanding with respect to certain accounting and auditing matters. The designation does not impose upon an Audit Committee member any duties, obligations or liability that are greater than are generally imposed on him as a member of the Audit Committee and the Board, and his designation as an audit committee financial expert pursuant to this SEC requirement does not affect the duties, obligations or liability of any other member of the Audit Committee or the Board.
      The report of the Audit Committee is included herein on page 27.
      Corporate Governance Committee. The Corporate Governance Committee oversees the Company’s disclosure controls and procedures, except for the financial reporting controls and procedures overseen by the Audit Committee, and recommends to the Board the adoption of any measures it deems advisable for the improvement of disclosure controls and procedures. As of July 1, 2005, our Corporate Governance Committee consisted of Messrs. Christoffersen, Chang and Reddy. Mr. Christoffersen serves as chairman of this committee. The Corporate Governance Committee met two times during the fiscal year ended March 31, 2005, in conjunction with regularly scheduled Board meetings.
      Nominating Committee. The Nominating Committee is responsible for seeking, screening and recommending for nomination candidates for election to the Board of Directors. In so doing, the Nominating Committee may evaluate, among other things:
  •  the current size, composition and needs of the Board and its committees;
 
  •  such factors as judgment, independence, character and integrity, area of expertise, diversity of experience, length of service, and potential conflicts of interest of candidates; and
 
  •  such other factors as the Committee may consider appropriate.
      These factors, and any other qualifications considered useful by the Nominating Committee, are reviewed in the context of an assessment of the perceived needs of the Board at a particular point in time. As a result, the priorities and emphasis of the Nominating Committee and of the Board may change from time to time to take into account changes in business and other trends, and the portfolio of skills and experience of current and prospective Board members. Therefore, the Nominating Committee has not established any specific minimum criteria or qualifications that a nominee must possess. The current Nominating Committee charter is available at our Web site located at www.gnss.com.
      The Nominating Committee will evaluate candidates identified on its own initiative as well as candidates referred to it by other members of the Board, by our management, by stockholders who submit names to the Nominating Committee, or by other external sources. With regard to the newest nominees for election as Class I directors, the Nominating Committee recommended and the Board approved the nominations of Messrs. Christoffersen and Kidd for election as Class I directors at the 2005 annual meeting. Since our last annual meeting in 2004, we have not employed a search firm or paid fees to other third parties in connection with seeking or evaluating Board nominee candidates.

8


Table of Contents

      With regard to referrals from our stockholders, the Nominating Committee’s policy is to consider recommendations for candidates to the Board of Directors from stockholders holding not less than 1% of our outstanding common stock continuously for at least twelve months prior to the date of the submission of the recommendation. Candidates suggested by stockholders are evaluated using the same criteria as for other candidates. A stockholder that desires to recommend a candidate for election to the Board shall direct the recommendation in written correspondence by letter to Genesis Microchip Inc., attention of the Company’s Secretary, at our offices at 2150 Gold Street, Alviso, California 95002. Such notice must include the candidate’s name, home and business contact information, detailed biographical data, relevant qualifications, a signed letter from the candidate confirming willingness to serve, information regarding any relationships between the candidate and Genesis within the last three years, evidence of the required ownership of common stock by the recommending stockholder, and to the extent known by the stockholder, any relationships between the candidate and competitors, customers, suppliers and any other parties that might give rise to the appearance of a potential conflict of interest. Any stockholder who wishes to make a direct nomination for election to the Board at an annual or special meeting for the election of directors must comply with procedures set forth in our bylaws.
      As of July 1, 2005, our Nominating Committee consisted of Mr. Diamond, Mr. Castor and Mr. Kidd, each of whom is “independent” in accordance with the published listing requirements of Nasdaq. Mr. Diamond serves as chairman of this committee. The Nominating Committee held three meetings during the fiscal year ended March 31, 2005.
      Annual Meeting Attendance. The Company does not have a formal policy regarding the attendance of its directors at annual or special meetings of stockholders, but the Company encourages directors to attend such meetings. Of the three directors elected at the November 3, 2004 annual meeting and the four continuing directors not elected at that meeting, all seven directors attended that meeting.
Compensation of Directors
      Directors who are not our employees receive $5,000 per quarter as a retainer, $1,000 for each meeting of the Board of Directors or committee thereof attended in person and $500 for each meeting attended by teleconference. Non-employee chairmen of committees receive an additional retainer of $1,250 per quarter for serving as a committee chairman, other than the chairman of the audit committee who receives an additional quarterly retainer of $2,500. Directors who are our employees receive no separate compensation for services rendered as a director. All directors are reimbursed for reasonable expenses to attend meetings.
      Non-employee directors automatically receive stock options under the terms of our 1997 Non-Employee Stock Option Plan. Upon first joining the board, non-employee directors receive an option to purchase 15,000 shares of our common stock. Those options are granted with an exercise price equal to the closing price of our stock on the last trading day before joining the board. Non-employee directors also automatically receive an option to purchase 10,000 shares of our common stock under our 2000 Nonstatutory Stock Option Plan upon first joining the Board. Since the option pool in our 1997 Non-Employee Stock Option Plan is nearly depleted, we intend to grant some of the stock options described above from our 2000 Nonstatutory Stock Option Plan or our 2001 Nonstatutory Stock Option Plan.
      Grants are also made annually on the first day of the month following our annual meeting of stockholders. Each non-employee director receives an option to purchase 10,000 shares of our common stock plus 2,500 shares of our common stock for each committee on which the director serves. The options are granted with an exercise price equal to the closing price of our stock on the day preceding the date of the grant and vest over twelve months. The automatic annual option grants were made on December 1, 2004 at an exercise price of $16.94 per share. No other stock option grants were made to non-employee directors in fiscal 2005.
      Non-employee directors may also be granted stock options under the terms of our 2000 Nonstatutory Stock Option Plan or our 2001 Nonstatutory Stock Option Plan.

9


Table of Contents

      The following table summarizes the retainers and attendance fees and the number of stock option grants that were made to our non-employee directors, in their capacity as non-employee directors, during fiscal 2005:
                                 
            Discretionary   Retainers and
    Initial Option   Automatic Annual   Option   Attendance
Name   Grants   Grants   Grants   Fees ($)
                 
Jon Castor
    25,000                   19,333  
Chieh Chang
    25,000                   13,833  
Tim Christoffersen
          15,000             45,500  
Jeffrey Diamond
          15,000             43,667  
Eric Erdman
                      11,667  
Robert H. Kidd
          15,000             59,917  
Chandrashekar M. Reddy
          12,500             35,500  
PROPOSAL 2 — APPOINTMENT OF INDEPENDENT ACCOUNTANTS
      You are being asked to ratify the appointment of KPMG LLP in Canada as independent accountants for the fiscal year ending March 31, 2006.
      We have selected KPMG as our independent accountants for the 2006 fiscal year. KPMG or its predecessor firms have served as our independent accountants since our inception in Canada in 1987. Representatives of KPMG are expected to be present at the annual meeting. They will have the opportunity to make a statement if they desire to do so and will be available to respond to appropriate questions from you.
      The approximate fees billed to us by KPMG for services rendered with respect to fiscal years 2005 and 2004 were as follows:
                 
    2005   2004
         
Audit Fees
  $ 833,023     $ 471,468  
Audit-Related Fees
    218,843       49,200  
Tax Fees
    522,529       377,371  
             
Total Fees
    1,574,395       898,039  
      Audit Fees. This category consists of fees paid for professional services provided in connection with the integrated audit of our financial statements and internal controls over financial reporting, and review of our quarterly financial statements and audit services provided in connection with other statutory or regulatory filings, including filings related to potential mergers and acquisitions.
      Audit-Related Fees. This category consists of fees paid primarily for advisory services, research on accounting matters and due diligence related to mergers and acquisitions, and are not reported above under “Audit Fees.”
      Tax Fees. This category consists of fees paid primarily for professional services rendered by KPMG in connection with tax advice related to specialized projects such as the implementation of the American Jobs Creation Act, acquisition activities and tax compliance, including technical tax advice related to the preparation of tax returns.
      The Audit Committee has determined that the provision of non-audit services performed during fiscal 2005, including work related to acquisition activities and for tax planning and compliance purposes, is compatible with maintaining the independence of KPMG.
      The Audit Committee has established a policy governing our use of KPMG for non-audit services. Under the policy, management may use KPMG for non-audit services that are permitted under SEC rules and regulations, provided that management obtains the Audit Committee’s approval before such services are rendered. In fiscal 2005, all fees identified above under the captions “Audit-Related Fees” and

10


Table of Contents

“Tax Fees” that were billed by KPMG were approved by the Audit Committee pursuant to the Company’s pre-approval policies and procedures established by the Audit Committee.
      The resolution must be passed by a majority of the votes cast at our annual meeting (which majority must also constitute at least a majority of the required quorum) to be approved. The persons named in the enclosed proxy intend to vote the shares represented by those proxies in favor of this resolution.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE RATIFICATION OF THE
APPOINTMENT OF KPMG LLP IN CANADA AS OUR INDEPENDENT ACCOUNTANTS FOR THE FISCAL YEAR ENDING MARCH 31, 2006.
TRANSACTION OF OTHER BUSINESS
      We know of no other proposals to be presented at the meeting. If any other proposal is presented, the shares represented by the proxies we receive will be voted according to the best judgment of the persons named in the proxies. It is the intention of the persons named in the form of proxy to vote the shares that those proxies represent as the Board of Directors recommends.

11


Table of Contents

EQUITY COMPENSATION PLAN INFORMATION
      The following table provides information as of March 31, 2005 about our common stock that may be issued upon the exercise of options, warrants and rights under our 1997 Employee Stock Purchase Plan described above as well as our eight stock option plans: the 1987 Stock Option Plan, the 1997 Employee Stock Option Plan, the 1997 Non-Employee Stock Option Plan, the 2000 Non-Statutory Stock Option Plan, the 2001 Non-Statutory Stock Option Plan, the 1997 Paradise Stock Option Plan, the Sage Stock Option Plan, and the 2003 Stock Plan.
      The 1997 Paradise Stock Option Plan and the Sage Stock Option Plan, under which we do not grant any new options, were assumed upon our acquisitions of other companies. Our stockholders have not formally approved our 2000 Non-Statutory Stock Option Plan, although they approved an amendment to that plan at the September 14, 2000 annual meeting. Our stockholders have not approved our 2001 Non-Statutory Stock Option Plan or our 2003 Stock Plan. Our stockholders have approved all other plans.
                         
            Number of
            Securities
            Available for
            Issuance Under
    Number of       Equity
    Securities to       Compensation
    Be issued   Weighted-average   Plans
    upon Exercise   Exercise Price of   (Excluding
    of Outstanding   Outstanding   Securities
    Options,   Options,   Reflected in
    Warrants and   Warrants and   the First
Plan Name and Type   Rights   Rights   Column)
             
Equity compensation plans approved by stockholders
                       
1997 Employee Stock Purchase Plan*
    N/A       N/A       330,870  
1987 Stock Option Plan
    1,047       9.00        
1997 Employee Stock Option Plan
    3,907,824       14.40       551,265  
1997 Non-Employee Stock Option Plan
    272,563       15.63       9,675  
Equity compensation plans not formally approved by stockholders
                       
2000 Non-Statutory Stock Option Plan
    2,561,649       14.05       497,218  
2001 Non-Statutory Stock Option Plan
    527,869       18.36       17,274  
2003 Stock Plan
    925,000       17.09       75,000  
Equity compensation plans assumed on acquisitions
                       
1997 Paradise Stock Option Plan
    5,887       1.70        
Sage Stock Option Plan
    603,384       19.73        
Total*
    8,805,223       15.22       1,481,302  
 
The number of securities to be issued upon exercise of outstanding rights under the 1997 Employee Stock Purchase Plan and the weighted average exercise price of those securities is not determinable. The 1997 Employee Stock Purchase Plan provides that shares of our common stock may be purchased at a per share price equal to 85% of the fair market value of the common stock on the beginning of the offering period or a purchase date applicable to such offering period, whichever is lower. The closing price per share of our common stock on the Nasdaq National Market on December 31, 2004 (the last trading day of the most recent offering period) was $16.22.

12


Table of Contents

      Summaries of the stock option plans not formally approved by our stockholders are as follows:
2000 Non-Statutory Stock Option Plan
Purpose
      The purposes of the plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to employees and consultants and to promote the success of our business.
Administration
      The plan provides for administration by our Board of Directors or a committee appointed by the Board and is currently administered by the Compensation Committee of the Board of Directors. All questions of interpretation or application of the plan are determined by the Board of Directors or its appointed committee, and its decisions are final and binding upon all participants. Directors receive no additional compensation for their services in connection with the administration of the plan.
Eligibility to Participate in the Plan
      Nonstatutory stock options may be granted to our employees, consultants and directors.
Number of Shares Covered by the Plan
      The aggregate number of shares of common stock authorized for issuance under the plan is 1,500,000 shares plus an annual increase to be added on the first day of each fiscal year equal to the lesser of (i) 2,000,000 shares, (ii) 3.5% of the Company’s outstanding shares of common stock on such date, or (iii) a lesser amount determined by the Board.
Awards Permitted under the Plan
      The plan authorizes the granting of nonstatutory stock options only.
Terms of Options
      The plan’s administrator determines the exercise price of options granted under the plan and the term of those options. The options that are currently outstanding under the plan vest and become exercisable over periods of from one to four years beginning on the grant date. Payment of the exercise price may be made by cash, check, promissory note, other shares of our common stock, cashless exercise, any other form of consideration permitted by applicable law or any combination of the foregoing methods of payment. Options may be made exercisable only under the conditions the Board of Directors or its appointed committee may establish. If an optionee’s employment terminates for any reason, the option remains exercisable for a period fixed by the plan administrator up to the remainder of the option’s term; if a period is not fixed by the plan administrator, the exercise period is three (3) months, or twelve (12) months in the case of death or disability.
Capital Changes
      In the event of any changes in our capitalization, such as stock splits or stock dividends, resulting in an increase or decrease in the number of shares of common stock, effected without receipt of consideration by us, appropriate adjustment will be made by us in the number of shares available for future grant and in the number of shares subject to previously granted but unexercised options.
Dissolution or Liquidation
      In the event of the proposed dissolution or liquidation of our Company, the option holders will be notified of such event, and the plan administrator may, in its discretion, permit each option to fully vest and be exercisable until ten (10) days prior to such event, at which time the options will terminate.

13


Table of Contents

Merger, Asset Sale or Change of Control
      With respect to options granted on or before October 16, 2001 (unless the optionees have consented otherwise), in the event of a merger of our Company with or into another corporation, or any other capital reorganization in which more than fifty percent (50%) of the outstanding voting shares of the Company are exchanged (other than a reorganization effected solely for the purpose of changing the situs of the Company’s incorporation), each outstanding option under the plan will fully vest and be exercisable for a period often (10) days prior to the closing of such transaction, and the unexercised options will terminate prior to the closing of such transaction.
      With respect to options granted after October 16, 2001 (as well as certain options granted before such date, with the consent of the optionees), in the event of a merger or proposed sale of all or substantially all of the assets of our Company, each outstanding option under the plan will be assumed or an equivalent option substituted by the successor corporation or a parent or subsidiary of the successor corporation. In the event the successor corporation refuses to assume or substitute outstanding options, the plan administrator will notify each optionee that his or her options will vest and be exercisable for a period of twenty (20) days from the date of such notice, and the unexercised options will terminate upon the expiration of such period.
Nonassignability
      Options may not be assigned or transferred for any reason (other than upon death), except that the plan administrator may permit options to be transferred during the optionee’s lifetime to members of the optionee’s immediate family or to trusts, LLCs or partnerships for the benefit of such persons.
Amendment and Termination of the Plan
      The plan provides that the Board of Directors may amend or terminate the plan without stockholder approval, but no amendment or termination of the plan or any award agreement may adversely affect any award previously granted under the plan without the written consent of the optionee.
Certain United States Federal Income Tax Information
      An optionee generally will not recognize any taxable income at the time he or she is granted a non-statutory stock option. However, upon its exercise, the optionee will recognize ordinary income generally measured as the excess of the then fair market value of the shares purchased over the purchase price. Any taxable income recognized in connection with an option exercise by one of our employees is subject to tax withholding by us. Upon resale of such shares by the optionee, any difference between the sales price and the optionee’s purchase price, to the extent not recognized as taxable income as described above, will be treated as long-term or short-term capital gain or loss, depending on the holding period.
      Generally, we will be entitled to a tax deduction in the same amount as the ordinary income realized by the optionee with respect to shares acquired upon exercise of the non-statutory stock option.
      The foregoing is only a summary of the effect of federal income taxation upon the optionee and us with respect to the grant and exercise of options granted under the plan and does not purport to be complete. In addition, the summary does not discuss the tax consequences of an optionee’s death or the income tax laws of any state or foreign country in which the optionee may reside.
2001 Non-Statutory Stock Option Plan
Purpose
      The purposes of the plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to employees, directors and consultants and to promote the success of our business.

14


Table of Contents

Administration
      The plan provides for administration by our Board of Directors or a committee appointed by the Board and is currently administered by the Compensation Committee of the Board of Directors. All questions of interpretation or application of the plan are determined by the Board of Directors or its appointed committee, and its decisions are final and binding upon all participants. Directors receive no additional compensation for their services in connection with the administration of the plan.
Eligibility to Participate in the Plan
      Nonstatutory stock options may be granted to our employees including officers, consultants and directors.
Number of Shares Covered by the Plan
      The aggregate number of shares of common stock authorized for issuance under the plan is 1,000,000 shares.
Awards Permitted under the Plan
      The plan authorizes the granting of nonstatutory stock options only.
Terms of Options
      The plan’s administrator determines the exercise price of options granted under the plan and the term of those options. The options that are currently outstanding under the plan vest and become exercisable over periods of two to four years beginning on the grant date. Payment of the exercise price may be made by cash, check, promissory note, other shares of our common stock, cashless exercise, a reduction in the amount of any Company liability to the optionee, any other form of consideration permitted by applicable law or any combination of the foregoing methods of payment. Options may be made exercisable only under the conditions the Board of Directors or its appointed committee may establish. If an optionee’s employment terminates for any reason, the option remains exercisable for a period fixed by the plan administrator up to the remainder of the option’s term; if a period is not fixed by the plan administrator, the exercise period is three (3) months, or twelve (12) months in the case of death or disability.
Capital Changes
      In the event of any changes in our capitalization, such as stock splits or stock dividends, resulting in an increase or decrease in the number of shares of common stock, effected without receipt of consideration by us, appropriate adjustment will be made by us in the number of shares available for future grant and in the number of shares subject to previously granted but unexercised options.
Dissolution or Liquidation
      In the event of the proposed dissolution or liquidation of our Company, the option holders will be notified of such event, and the plan administrator may, in its discretion, permit each option to fully vest and be exercisable until ten (10) days prior to such event, at which time the options will terminate.
Merger, Asset Sale or Change of Control
      In the event of a merger or proposed sale of all or substantially all of the assets of our Company, each outstanding option under the plan will be assumed or an equivalent option substituted by the successor corporation or a parent or subsidiary of the successor corporation. In the event the successor corporation refuses to assume or substitute outstanding options, the plan administrator will notify each optionee that his or her options will vest and be exercisable for a period of fifteen (15) days from the date of such notice, and the unexercised options will terminate upon the expiration of such period.

15


Table of Contents

Nonassignability
      Options may not be assigned or transferred for any reason (other than upon death), except that the plan administrator may permit options to be transferred during the optionee’s lifetime upon such terms and conditions as the administrator deems appropriate.
Amendment and Termination of the Plan
      The plan provides that the Board of Directors may amend or terminate the plan without stockholder approval, but no amendment or termination of the plan or any award agreement may adversely affect any award previously granted under the plan without the written consent of the optionee.
Certain United States Federal Income Tax Information
      An optionee generally will not recognize any taxable income at the time he or she is granted a non-statutory stock option. However, upon its exercise, the optionee will recognize ordinary income generally measured as the excess of the then fair market value of the shares purchased over the purchase price. Any taxable income recognized in connection with an option exercise by one of our employees is subject to tax withholding by us. Upon resale of such shares by the optionee, any difference between the sales price and the optionee’s purchase price, to the extent not recognized as taxable income as described above, will be treated as long-term or short-term capital gain or loss, depending on the holding period.
      Generally, we will be entitled to a tax deduction in the same amount as the ordinary income realized by the optionee with respect to shares acquired upon exercise of the nonstatutory stock option.
      The foregoing is only a summary of the effect of federal income taxation upon the optionee and us with respect to the grant and exercise of options granted under the plan and does not purport to be complete. In addition, the summary does not discuss the tax consequences of an optionee’s death or the income tax laws of any state or foreign country in which the optionee may reside.
2003 Stock Plan
      In October 2003, the Board approved the 2003 Stock Plan (the “Plan”). The Plan provides for the grant of non-statutory stock options, stock purchase rights, restricted stock, stock appreciation rights, performance shares, and performance units, to newly hired employees as a material inducement to their decision to enter into our employ.
      Awards under the Plan may not be granted to individuals who are former employees or directors of ours, except that a former employee who is returning to our employ following a bona-fide period of non-employment by us may receive awards under the Plan. Our Board or a committee appointed by the Board administers the Plan and controls its operation (the “Administrator”). However, all awards under the Plan must be approved by either a majority of our independent directors, or approved by a committee comprised of a majority of independent directors.
      The Administrator determines, on a grant-by-grant basis, the term of each option, when options granted under the Plan will vest and may be exercised, the exercise price of each option, and the method of payment of the option exercise price. After a participant’s termination of service with us, the vested portion of his or her option will generally remain exercisable for the period of time stated in the option agreement. If a specified period of time is not stated in the option agreement, the option will remain exercisable for three months following a termination for reasons other than death or disability, and for one year following a termination due to death or disability, in each case subject to the original term of the option. The Administrator also determines the terms and conditions of restricted stock awards (shares that vest in accordance with the terms and conditions established by the Administrator), stock purchase rights (rights to purchase shares of our common stock, and such shares are generally restricted stock), stock appreciation rights (the right to receive the appreciation in fair market value of our common stock between the exercise date and the date of grant), and performance shares and/or units (awards that will result in a payment to a participant only if the

16


Table of Contents

performance goals or other vesting criteria established by the Administrator are achieved or the awards otherwise vest).
      In the event we experience a change in control, each outstanding option, stock purchase right and stock appreciation right will be assumed or substituted for by the successor corporation (or a parent or subsidiary of such successor corporation). If such awards are not so assumed or substituted, the Administrator will notify participants that their options, stock purchase rights, and stock appreciation rights will be exercisable as to all of the shares subject to the award for a period of time determined by the Administrator in its sole discretion, and that the award will terminate upon the expiration of such period. In addition, in the event we experience any dividend or other distribution, recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of shares or other securities, or other change in our corporate structure affecting the shares occurs, the Administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the Plan may make appropriate adjustments to outstanding awards and to the shares available for issuance under the Plan.
      There are 1,000,000 shares of our common stock reserved under the Plan, and as of March 31, 2005, 75,000 shares remain for future issuance. By its terms, the Plan will automatically terminate in 2013, unless earlier terminated by the Board.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
      The following table contains information about the beneficial ownership of our common stock as of July 1, 2005, for:
  •  each of our current directors and director nominees, as well as our Chief Executive Officer as of March 31, 2005 and our other four most highly compensated executive officers during the fiscal year ended March 31, 2005;
 
  •  all of our current directors and named executive officers as a group; and
 
  •  all persons known by us to be beneficial owners of more than five percent (5%) of our outstanding stock.
      The number and percentage of shares beneficially owned is determined in accordance with Rule 13d-3 of the Securities and Exchange Act of 1934 and the information is not necessarily indicative of beneficial ownership for any other purpose. Under Rule 13d-3, beneficial ownership includes any shares over which the individual or entity has voting power or investment power and any shares that the individual has the right to acquire within 60 days of July 1, 2005 through the exercise of any stock options. Unless indicated, each person or entity either has sole voting and investment power over the shares shown as beneficially owned or shares those powers with his spouse.
      The number of options exercisable within sixty (60) days of July 1, 2005 is shown in the first column of the table and is included in the total number of shares of common stock beneficially owned shown in the second column. The percentage of shares beneficially owned is computed on the basis of 34,120,813 shares of

17


Table of Contents

common stock outstanding on July 1, 2005. Unless otherwise indicated, the principal address of each stockholder listed below is c/o Genesis Microchip Inc., 2150 Gold Street, Alviso, California 95002.
                           
    Number of   Total Number    
    Shares of   of Shares of   Percentage of
    Common Stock   Common Stock   Outstanding
    Issuable Pursuant   Beneficially   Common
Name   to Options   Owned   Stock
             
Mazama Capital Management, Inc.(1)
          4,197,435       12.3 %
  One S.W. Columbia, Suite 1500
Portland, Oregon 97258
                       
Kennedy Capital Management, Inc.(2)
          3,711,549       10.9 %
  10829 Olive Blvd.
St. Louis, Missouri 63141
                       
Mellon Financial Corporation(3)
          1,864,089       5.5 %
  One Mellon Center
Pittsburg, Pennsylvania 15258
                       
Elias Antoun
          1,269       *  
Michael Healy
    75,000       77,278       *  
Anders Frisk
    144,575       147,156       *  
Raphael Mehrbians
    85,452       86,918       *  
Tzoyao Chan(4)
    188,160       220,115       *  
Mohammad Tafazzoli
    123,834       128,317       *  
Jon Castor
    11,250       11,250       *  
Chieh Chang
    11,250       24,987       *  
Tim Christoffersen
    46,250       46,250       *  
Jeffrey Diamond(5)
    102,500       117,054       *  
Eric Erdman
    389,193       397,824       1.2 %
Robert H. Kidd
    52,500       52,500       *  
Chandrashekar M. Reddy
    37,500       219,055       *  
Directors and Executive Officers as a group (16 persons)(4)(5)
    1,429,849       1,529,973       4.5 %
 
Less than one percent (1%)
(1)  Based on information contained in a Schedule 13G/ A filed February 14, 2005.
 
(2)  Based on information contained in a Schedule 13G/ A filed February 15, 2005.
 
(3)  Based on information contained in a Schedule 13G/ A filed February 11, 2005.
 
(4)  Includes 30,004 shares directly owned and 19,489 shares owned by YTCC Foundation and T. Chan & W. Chen Charitable Remainder Unitrust, both trusts established for the benefit of Dr. Chan and his family.
 
(5)  Includes 14,554 shares owned by Diamond Family Trust, a trust established for the benefit of Mr. Diamond and his family.

18


Table of Contents

SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
      Section 16(a) of the Securities Exchange Act of 1934 requires our officers, directors and any person who owns more than ten percent (10%) of our shares of common stock to file reports of ownership on Forms 3, 4 and 5 with the Securities and Exchange Commission and with us. Based on our review of copies of forms and written representations, we believe that all of our officers, directors and greater than ten percent (10%) stockholders complied with all filing requirements applicable to them for the year ended March 31, 2005, except as follows:
  •  On November 10, 2004, we entered into Amendment No. 1 to the Separation Agreement and Release with Chandrashekar M. Reddy, which extended the exercise date to May 30, 2005 for certain options to purchase an aggregate of 46,346 shares of common stock, which were to expire on November 11, 2004. This amendment was first reported on Form 8-K dated November 15, 2004, followed by a Form 4 dated November 23, 2004.
 
  •  On May 26, 2004, Young Ahn was appointed as our Vice President, Worldwide Sales and an executive officer, which such event was first reported on a Form 3 on June 23, 2004. Also on May 26, 2004, Mr. Ahn was granted an option to purchase 50,000 shares of our common stock, which such grant was first reported on a Form 4 dated June 23, 2004. Mr. Ahn resigned on December 28, 2004.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
      See the disclosure under the caption entitled “Employment contracts, termination of employment and change-in-control arrangements” on the next page.
Executive Compensation
Summary Compensation Table
      The following table contains information about compensation paid to our Chief Executive Officers and to our five other most highly compensated executive officers for our fiscal year ended March 31, 2005 and the compensation of those individuals in fiscal years 2004 and 2005, where applicable.
                                           
                Long Term Compensation
             
        Annual Compensation   Securities    
    Fiscal       Underlying   All Other
    Year   Salary ($)   Bonus ($)   Options (#)   Compensation ($)
                     
Elias Antoun(1)
    2005       119,360             500,000       2,100  
  Chief Executive Officer and President                                        
Eric Erdman(2)
    2005       213,017       51,325       50,000       357,078  
  Former Chief Financial Officer and     2004       245,347       70,000       130,000       66,311  
  Former Interim Chief Executive Officer     2003       212,709       28,881       70,000        
Michael Healy
    2005       220,008       80,000             7,200  
  Chief Financial Officer     2004       34,270             200,000       1,200  
Anders Frisk
    2005       259,999       252,100       43,000       7,200  
  Executive Vice President     2004       250,000             20,000       100  
        2003       242,633             137,500        
Tzoyao Chan
    2005       224,231             36,500       7,200  
  Senior Vice President, Product     2004       210,000             50,000          
  Development     2003       201,667             60,000        
Raphael Mehrbians
    2005       222,538             51,667       58,556  
  Senior Vice President, Product     2004       193,249             50,000       58,220  
  Marketing     2003       175,008             70,000        
Mohammad Tafazzoli
    2005       220,000             40,000       7,200  
  Senior Vice President, Operations     2004       210,000             50,000        
        2003       204,075             60,000        

19


Table of Contents

 
(1)  Mr. Antoun became our Chief Executive Officer and President on November 29, 2004. For details regarding his employment agreement, see description under the caption “Employment Agreements with Mr. Antoun.”
 
(2)  Mr. Erdman was Interim Chief Executive Officer effective July 20, 2003 until November 29, 2004. Mr. Erdman served as both Interim Chief Executive Officer and Chief Financial Officer from July 20, 2003 to February 15, 2004, for which he received a bonus and certain other amounts in fiscal 2004 pursuant to his employment agreement, which are reflected under “Bonus” and “All Other Compensation.” For details regarding his employment agreement, see the description under the caption, “Separation Agreement and Release with Mr. Erdman.”
Employment contracts, termination of employment and change-in-control arrangements
Employment Agreement with Mr. Antoun
      On November 10, 2004 and November 29, 2004, respectively, we entered into an employment letter and change of control severance agreement with Mr. Antoun, currently our Chief Executive Officer and President. The employment letter states that Mr. Antoun’s initial base salary is $350,004. In addition, Mr. Antoun receives a car allowance and is eligible to participate in any applicable corporate bonus plan. The change of control severance agreement provides certain benefits upon an involuntary termination of employment following a change of control of Genesis, as set forth below under the heading “Employment and severance agreements relating to change of control.”
Separation Agreement and Release with Mr. Erdman
      We entered into a Settlement Agreement and Release with Mr. Erdman, our former Interim Chief Executive Officer and former Chief Financial Officer, in connection with his resignation effective November 29, 2004. Under the agreement, Mr. Erdman was entitled to receive as severance a lump-sum payment equal to one year of his base salary, as well as (i) a bonus in the amount of $51,325.65, less applicable withholdings, based on Mr. Erdman’s eight months of employment with Genesis; (ii) reimbursement for up to 3 months of COBRA; (iii) commencing March 1, 2005 for a period of up to nine months, coverage under Genesis’s health plan for its Canadian employees or reimbursement for the payments made by Mr. Erdman for the continuation of post-termination health benefits as provided under Canadian law; (iv) reimbursement for reasonable moving expenses incurred by Mr. Erdman’s relocation from California to Canada; (v) reimbursement for certain return and tax advise, not to exceed $10,000; and (vi) reimbursement for legal fees and costs incurred in the preparation of the agreement and the Consulting Agreement, discussed below. Mr. Erdman agreed and authorized the Company to deduct from the lump-sum severance payment monies overpaid to Mr. Erdman by the Company in relation to his vehicle allowance. Mr. Erdman was also entitled to: (i) accelerated vesting for all stock options granted to Mr. Erdman on or prior to August 12, 2003; (ii) twelve months of additional vesting for all stock options granted to Mr. Erdman after August 12, 2003; and (iii) the right to exercise all vested stock options (including those vesting under the agreement) for a period of up to eighteen months following the effective date of Mr. Erdman’s termination. Mr. Erdman agreed to release all claims he may have had against the Company. Mr. Erdman also agreed to provisions concerning confidentiality, cooperation in litigation and non-solicitation of our employees and consultants. The agreement terminated our February 2004 Interim Chief Executive Officer employment agreement with Mr. Erdman, under which Mr. Erdman was to receive an annual base salary of $275,000, a one-time bonus for his service in both the Interim Chief Executive Officer and Chief Financial Officer positions and certain other benefits. Mr. Erdman and the Company entered into a Consulting Agreement, dated as of December 3, 2004, whereby Mr. Erdman was to provide services related to the transition of his duties as the Company’s former Interim Executive Officer at a rate of $10,000 per month, until March 31, 2005.
Employment Agreement with Mr. Healy
      On February 4, 2004, we entered into an employment letter and change of control severance agreement with Mr. Healy, currently our Senior Vice President, Finance and Chief Financial Officer. The employment

20


Table of Contents

letter states that Mr. Healy’s initial base salary is $220,000 and that he will receive a one-time guaranteed bonus of $80,000 at the end of twelve months of employment. In addition, Mr. Healy receives a car allowance and is eligible to participate in any applicable corporate bonus plan. The change of control severance agreement provides certain benefits upon an involuntary termination of employment following a change of control of Genesis, as set forth below under the heading “Employment and severance agreements relating to change of control.” In addition, if during Mr. Healy’s first two years of employment, he is involuntarily terminated without cause by our Chief Executive Officer (excluding an involuntary termination with or without cause by Eric Erdman), he will be entitled to receive similar severance benefits.
Employment Letter with Mr. Frisk
      On February 15, 2000, we entered into an employment letter with Anders Frisk, currently our Executive Vice President. In addition to base salary, bonus, car allowance and other benefits, we granted Mr. Frisk options for 130,000 shares of our common stock that have since fully vested. In addition, pursuant to an employment agreement with Mr. Frisk, in the event that his employment is involuntarily terminated at any time, he will be entitled to a lump sum payment equal to 12 months of his base salary in effect as of the date of his termination.
Employment Letter with Dr. Chan
      Dr. Chan, who currently serves as our Senior Vice President, Product Development, entered into an employment letter with Paradise Electronics, Inc., dated April 21, 1997, which we assumed upon our acquisition of Paradise. In addition to base salary, bonus and other benefits, Dr. Chan was granted stock options that have since fully vested.
Employment Letter with Mr. Mehrbians
      On February 28, 2002, we entered into an employment letter with Mr. Mehrbians, who currently serves as our Senior Vice President, Product Marketing. In addition to base salary, bonus and other benefits, Mr. Mehrbians was granted a stock option with standard four-year vesting. On February 28, 2002, which was prior to his becoming an officer of the Company and prior to the enactment of the Sarbanes-Oxley Act of 2002, we agreed to provide Mr. Mehrbians with a loan of $150,000, which amount has been forgiven pursuant to its requirement that Mr. Mehrbians remain employed by Genesis for three years.
Employment Letter with Mr. Tafazzoli
      Mr. Tafazzoli, who currently serves as our Senior Vice President, Operations, entered into an employment letter with Paradise Electronics, Inc., dated February 17, 1998, which we assumed upon our acquisition of Paradise. In addition to base salary, bonus and other benefits, Mr. Tafazzoli was granted a stock option that has since fully vested.
Employment and Severance Agreements Relating to Change of Control
      Messrs. Antoun and Healy have entered into change of control severance agreements that will provide certain benefits upon an involuntary termination of employment following a change of control of Genesis. The agreements generally provide that if, within 12 months after the change of control, or any other change of control of the combined company following a merger, the executive’s employment is involuntarily terminated and signs a release of claims, then the executive will be entitled to the following severance benefits:
  •  12 months of the executive’s base salary, payable in a lump sum;
 
  •  12 months of acceleration of vesting under all stock options, and 12 months of lapsing of Genesis’s right of repurchase with respect to all restricted stock, held by the executive prior to the change of control;

21


Table of Contents

  •  the ability to exercise all vested stock options being assumed by the acquiring company that were originally granted to the executive by Genesis prior to the change of control for a period of 2 years following the termination of employment; and
 
  •  health coverage and benefits at the same level of coverage as was provided immediately prior to termination, for up to 12 months following the termination of employment.
      The agreements also generally provide that if, in the second year after the change of control, or any other change of control of the combined company following a merger, the executive’s employment is involuntarily terminated, then the executive will be entitled to the following severance benefits:
  •  a lump sum payment equal to the product of 100% of the executive’s monthly base salary, multiplied by the number of months remaining in such second year as of the employment termination date;
 
  •  12 months of acceleration of vesting under all stock options, and 12 months of lapsing of Genesis’s right of repurchase with respect to all restricted stock, held by the executive prior to the change of control;
 
  •  the ability to exercise all vested stock options granted to the executive by Genesis prior to the change of control for a period of 2 years following the termination of employment; and
 
  •  health coverage and benefits at the same level of coverage as was provided immediately prior to termination, for that number of months remaining in such second year as of the employment termination date.
Options granted in the year ended March 31, 2005
      The following table contains information about stock option grants made during the year ended March 31, 2005 to our Chief Executive Officers and to our five other most highly compensated executive officers in fiscal 2005. The stock options were granted under our 1997 Employee Stock Option Plan, our 2001 Nonstatutory Stock Option Plan, our 2000 Nonstatutory Stock Option Plan or our 2003 Nonstatutory Stock Option Plan. They have a maximum term of ten years, subject to earlier termination upon cessation of service.
      The 5% and 10% assumed annual rates of compounded stock price appreciation are mandated by rules of the Securities and Exchange Commission. There is no assurance that the actual stock price appreciation over the option terms will be at the assumed 5% and 10% levels or at any other defined level. Unless the market price of our common stock appreciates over the term of the option, no value will be realized from the option grants made to the executive officer.
                                     
    Individual Grants        
         
        % of Total       Potential Realizable Value
    Number of   Options       at Assumed Annual Rates of
    Securities   Granted to       Stock Price Appreciation for
    Underlying   Employees   Exercise       Option Term(2)
    Options   in Fiscal   Price per   Expiration    
Name   Granted   Year   Share   Date   5%   10%
                         
Elias Antoun(1)
    500,000       18.3 %   $ 16.895     11/29/2014   5,312,587   13,463,139
Eric Erdman(2)
    50,000       1.8 %   $ 15.62     5/26/2014   491,167   1,244,713
Michael Healy
                       
Anders Frisk
    40,000       1.5 %   $ 15.62     5/26/2014   392,933   995,770
      3,000       *     $ 15.76     12/28/2014   29,734   75,352
Tzoyao Chan
    35,000       1.3 %   $ 15.62     5/26/2014   343,817   871,299
      1,500       *     $ 15.76     12/28/2014   14,867   37,676
Raphael Mehrbians(3)
    51,667       1.9 %   $ 13.77     6/30/2014   447,430   1,133,875
Mohammad Tafazzoli
    40,000       1.5 %   $ 15.62     5/26/2014   392,933   995,770

22


Table of Contents

 
  * Less than 1 percent.
(1)  Mr. Antoun became Chief Executive Officer on November 29, 2004.
 
(2)  Mr. Erdman resigned as Interim Chief Executive Officer on November 29, 2004.
 
(3)  16,667 of the securities underlying these options were granted pursuant to an Option Exchange Agreement.
Aggregate option exercises in the last fiscal year and fiscal year-end option values
      The following table contains information about option exercises for our Chief Executive Officers and our five other most highly compensated executive officers in the year ended March 31, 2005 and their option holdings as of March 31, 2005.
      The value of an in-the-money stock option represents the difference between the aggregate estimated fair market value of the underlying stock and the aggregate exercise price of the stock option. We have used the reported closing price of $14.45 per share on The Nasdaq National Market on March 31, 2005 as the estimated fair market value of our common stock in determining the value of unexercised options.
                                                 
            Number of Securities    
            Underlying   Value of Unexercised
    Number of       Unexercised Options at   in-the-Money Options
    Shares       Fiscal Year End   at the Fiscal Year End ($)
    Acquired on   Value        
Name   Exercise   Received   Exercisable   Unexercisable   Exercisable   Unexercisable
                         
Elias Antoun(1)
                0       500,000              
Eric Erdman(2)
                389,193       0       1,285,485        
Michael Healy
                54,167       145,833              
Anders Frisk
                192,169       108,333       532,385       212,177  
Tzoyao Chan
                164,516       86,040       571,396       143,582  
Raphael Mehrbians
                67,292       94,375       255,010       220,074  
Mohammad Tafazzoli
                99,773       90,207       208,500       139,000  
 
(1)  Mr. Antoun became Chief Executive Officer on November 29, 2004.
 
(2)  Mr. Erdman resigned as Interim Chief Executive Officer on November 29, 2004.
Compensation Committee interlocks and insider participation
      The members of our Compensation Committee during the fiscal year ended March 31, 2005 were Messrs. Diamond and Chang. At no time since our formation have any of the members of our Compensation Committee served as our officers or employees or as officers or employees of any of our subsidiaries, except for Mr. Diamond as described in his biography on page 7. No interlocking relationship exists between our Board of Directors or its Compensation Committee and the board of directors or compensation committee of any other company, nor did any interlocking relationships exist during the past fiscal year.
COMPENSATION COMMITTEE’S REPORT ON EXECUTIVE COMPENSATION
To our Stockholders:
      We are responsible for reviewing and/or establishing the compensation programs that relate to Genesis’s executive officers, senior management and other key employees and for establishing the specific short and long-term compensation elements thereunder. We oversee the general compensation structure for all of Genesis’s employees and we administer the stock option and stock purchase plans. We are independent, non-employee directors.
      The executive compensation program that has been established is designed to provide levels of compensation in formats that assist Genesis in attracting, motivating and retaining qualified executives by

23


Table of Contents

providing a competitive compensation package geared to individual and corporate performance. We strive to establish performance criteria, evaluate performance and establish base salary, bonuses and long-term incentives for our key decision makers based upon performance and designed to provide appropriate incentives for maximization of our short and long-term financial results for the benefit of our stockholders.
      In order to meet our objectives, we have chosen four basic components for Genesis’s executive compensation program to meet our compensation philosophy. Base salaries, which are the fixed regular component of executive compensation, are based upon:
  •  base salary levels among a competitive, geographic peer group;
 
  •  Genesis’s past financial performance and future expectations;
 
  •  the general and industry-specific business environment; and
 
  •  individual performance.
      Bonuses, which are directly linked to Genesis’s performance, are designed to provide additional incentive cash compensation based on short-term performance of Genesis and its employees. Stock option grants, under the long-term component of executive compensation, are designed as an incentive to reward executive officers and employees for delivering value to our stockholders over a longer, measurable period of time. Historically, Genesis has used the grant of stock options that vest over some measurable period of time, generally four years, to accomplish this objective.
      The base salaries for our Chief Executive Officers in fiscal 2005, Mr. Elias Antoun and Mr. Eric Erdman, were determined with reference to base salaries for chief executive officers of other comparable technology companies. Mr. Antoun has served as our Chief Executive Officer since November 29, 2004 for which he received $119,360 in fiscal 2005 pursuant to his employment agreement. Mr. Erdman served as our Interim Chief Executive Officer from July 20, 2003 to November 29, 2004, for which he received a salary of $213,018, a bonus of $51,326, and severance of $285,000, in fiscal 2005 pursuant to his employment agreement and separation agreement. Incentive options to purchase 500,000 shares of our common stock were granted to Mr. Antoun upon his employment as Chief Executive Officer. Incentive options to purchase 50,000 shares of our common stock were granted to Mr. Erdman in May 2004. No other stock options were granted to Mr. Antoun or Mr. Erdman in fiscal 2005.
      The information contained in this report of the Compensation Committee shall not be deemed “soliciting material” or to be filed with the Securities and Exchange Commission, nor shall such information be incorporated by reference by any general statement incorporating by reference this proxy statement into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that Genesis specifically incorporates this information by reference, and shall not otherwise be deemed filed under such Acts.
  Respectfully submitted by the Compensation Committee,
 
  Jeffrey Diamond
  Chairman
 
  Chieh Chang
 
 
  July 28, 2005

24


Table of Contents

STOCK PERFORMANCE GRAPH
      The following performance graph compares the percentage change in the cumulative total stockholder return on shares of our common stock with the cumulative total return for:
  •  a group of our peer corporations, comprising the Nasdaq Electronic Components Stocks; and
 
  •  the Total Return Index for The Nasdaq Stock Market (US and Foreign).
      This comparison covers the period from March 31, 2000 to March 31, 2005, the last trading date in our 2005 fiscal year. It assumes $100 was invested on March 31, 2000 in shares of our common stock, our peer corporations and The Nasdaq Stock Market, and assumes reinvestment of dividends, if any.
      The Nasdaq Electronic Components Stocks consists of all corporations traded on The Nasdaq Stock Market with 367 as their primary standard industrial classification number. The Total Return Index for The Nasdaq Stock Market (US and Foreign) comprises all ADRs, domestic shares, and foreign common shares traded on The Nasdaq National Market and The Nasdaq Small Cap Market, excluding preferred shares, rights and warrants.
Comparative chart
(COMPARATIVE RETURNS CHART)
                             
                    
                Total Nasdaq
 Date     Genesis     Peer Group   Return
                    
 March 31, 2000
      100.00         100.00       100.00  
                       
 March 30, 2001
      45.70         31.29       39.91  
                       
 March 31, 2002
      119.54         33.21       40.14  
                       
 March 31, 2003
      57.38         19.15       29.30  
                       
 March 31, 2004
      77.01         33.40       43.62  
                       
 March 31, 2005
      66.44         26.72       44.02  
                       

25


Table of Contents

      The stock price performance shown on the graph is not necessarily indicative of future price performance. Our closing stock price on July 15, 2005, the record date, was $20.64. Information used on this graph was obtained from Nasdaq. Although we believe the information to be accurate, we are not responsible for any errors or omissions.
      This chart is not “soliciting material.” It is not deemed filed with the Securities and Exchange Commission and it is not to be incorporated by reference in any of our filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

26


Table of Contents

AUDIT COMMITTEE REPORT
      The Audit Committee is responsible for reviewing the scope and timing of audit services and any other services that Genesis’s independent accountants are asked to perform, the auditors’ report on Genesis’s consolidated financial statements following completion of their audit, and Genesis’s policies and procedures with respect to internal accounting and financial controls. The Board of Directors has adopted a written charter for the Audit Committee, which is available on our Web site located at www.gnss.com, and was filed as an Exhibit to our 2004 proxy statement. All members of this committee are independent members of the Board of Directors.
      We reviewed Genesis’s audited consolidated financial statements for fiscal year 2005 and discussed such statements with management. We discussed the matters required by Statement of Auditing Standards No. 61 (Communication with Audit Committees) with KPMG LLP in Canada, Genesis’s independent accountants during fiscal year 2005.
      We received the written disclosures and the letter required by Independent Standards Board Standard No. 1 (Independence Discussions with Audit Committees), as may be modified or supplemented, from KPMG LLP and discussed with them their independence. Based on the review and discussions noted above, we recommended to the Board of Directors that Genesis’s audited consolidated financial statements be included in its Annual Report on Form 10-K and the annual report to stockholders for the year ended March 31, 2005, and be filed with the U.S. Securities and Exchange Commission.
      The information contained in this report of the Audit Committee shall not be deemed “soliciting material” or to be filed with the Securities and Exchange Commission, nor shall such information be incorporated by reference by any general statement incorporating by reference this proxy statement into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that Genesis specifically incorporates this information by reference, and shall not otherwise be deemed filed under such Acts.
  Respectfully submitted by the Audit Committee,
 
  Robert H. Kidd
  Chairman
 
  Tim Christoffersen
 
  Jon Castor
July 28, 2005

27


Table of Contents

STOCKHOLDER PROPOSALS
      You may present proposals for inclusion in our proxy statement for consideration at our 2006 annual meeting by submitting them in writing to our Secretary in a timely manner. Pursuant to Rule 14a-8(e) of the Securities Exchange Act of 1934, as amended, your proposals must be received by us no later than March 29, 2006 to be included in the proxy statement for that meeting and must comply with the requirements of Rule 14a-8.
      Any proposals submitted by you after March 29, 2006, but on or before June 15, 2006, may be eligible for consideration at next year’s annual meeting, but will not be eligible for inclusion in the proxy statement for that meeting. Any proposal received after June 15, 2006 will be considered untimely for our 2006 annual meeting.
CONTACTING THE BOARD OF DIRECTORS
      Stockholders may communicate with the Board of Directors of the Company by sending an email to the Secretary of the Company at corporate.secretary@gnss.com. Alternatively, stockholders may communicate with the Board of Directors by mail at the following address: Board of Directors c/o Corporate Secretary, Genesis Microchip Inc., 2150 Gold Street, Alviso, California 95002. The Secretary will collect, organize and monitor these communications and will ensure that appropriate summaries of all received messages are provided to the Board of Directors at its regularly scheduled meetings. Stockholders who would like their submission directed to a specific director may so specify, and the communication will be so forwarded, as appropriate. Where the nature of a communication warrants, the Secretary may decide to obtain the more immediate attention of the appropriate committee of the Board of Directors or an independent director, or the Company’s management or independent advisors, as the Secretary considers appropriate.
  By order of the Board of Directors,
 
  /s/ Ava M. Hahn
 
 
  Ava M. Hahn
  Secretary
July 28, 2005

28


Table of Contents

PROXY
GENESIS MICROCHIP INC.
Proxy for the Annual Meeting of Stockholders
To be held on September 13, 2005
Solicited by the Board of Directors
     The undersigned hereby appoints Michael E. Healy and Ava M. Hahn, and each of them, with full power of substitution, to represent the undersigned and to vote all of the shares of stock in Genesis Microchip Inc., a Delaware corporation (the “Company”), which the undersigned is entitled to vote at the Annual Meeting of Stockholders of the Company to be held at 180 Baytech Drive, Suite 110, San Jose, California 95134 on September 13, 2005 at 10:00 a.m. Pacific Time, and at any adjournment or postponement thereof (i) as hereinafter specified upon the proposals listed on the reverse side and as more particularly described in the Proxy Statement of the Company dated on or about July 28, 2005 (the “Proxy Statement”), receipt of which is hereby acknowledged, and (ii) in their discretion upon such other matters as may properly come before the meeting.
THE SHARES REPRESENTED HEREBY SHALL BE VOTED AS SPECIFIED. IF NO SPECIFICATION IS MADE, SUCH
SHARES SHALL BE VOTED FOR THE NOMINEES FOR DIRECTOR INDICATED IN PROPOSAL 1 AND FOR PROPOSAL 2.
(continued and to be signed on the reverse side)
Address Change/Comments (Mark the corresponding box on the reverse side)
^ FOLD AND DETACH HERE ^

 


Table of Contents

     Access your Genesis Microchip shareholder account online via Investor ServiceDirect® (ISD).
     Mellon Investor Services LLC, agent for Genesis Microchip Inc., now makes it easy and convenient to get current information on your stockholder account. After a simple and secure process of establishing a Personal Identification Number (PIN), you are ready to log in and access your account to:

    View account status
 
    Make address changes
    View certificate history
 
    Establish/change your PIN


Visit us on the web at http://www.melloninvestor.com
and follow the instructions shown on this page.
Step 1: FIRST TIME USERS—Establish a PIN
     You must first establish a Personal Identification Number (PIN) online by following the directions provided in the upper right portion of the web screen as follows. You will also need your Social Security Number (SSN) available to establish a PIN.
     Investor ServiceDirect® is currently only available for domestic individual and joint accounts.
    SSN
 
    PIN
 
    Then click on the Establish PIN button
     Please be sure to remember your PIN, or maintain it in a secure place for future reference.
Step 2: Log in for Account Access
     You are now ready to log in. To access your account please enter your:
    SSN
 
    PIN
 
    Then click on the Submit button
     If you have more than one account, you will now be asked to select the appropriate account.
Step 3: Account Status Screen
     You are now ready to access your account information. Click on the appropriate button to view or initiate transactions.
    Certificate History
 
    Issue Certificate
 
    Address Change
Visit us on the web at http://www.melloninvestor.com
For Technical Assistance Call 1-877-978-7778 between 9am–7pm
Monday–Friday Eastern Time

 


Table of Contents

         
THE BOARD OF DIRECTORS RECOMMENDS A
  Please Mark Here for Address Change or
VOTE FOR THE NOMINEES FOR DIRECTOR
  Comments   o
INDICATED IN PROPOSAL 1 AND FOR
  SEE REVERSE SIDE    
PROPOSAL 2.
       
1.   Election of two (2) nominees to the Board of Directors.
Nominees:
01  Tim Christoffersen
02  Robert H. Kidd
         
FOR all nominees listed
  WITHHOLD AUTHORITY    
above (except as marked
  to vote for all nominees    
to the contrary below)
  listed above    
o
  o    
INSTRUCTION: To withhold authority to vote for an individual
nominee, write the nominee’s name in the space provided:
                 
2.
  To ratify the appointment of KPMG LLP in   FOR   AGAINST   ABSTAIN
 
  Canada as the Company’s independent   o   o   o
 
  accountants for the fiscal year ending March 31, 2006.            
WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING IN PERSON, YOU ARE URGED
TO SIGN AND PROMPTLY MAIL THIS PROXY CARD IN THE RETURN ENVELOPE
SO THAT YOUR STOCK MAY BE REPRESENTED AT THE MEETING.
                             
Signature:
      Date:       Signature:       Date:    
 
                           
Note: Sign exactly as your name(s) appear(s) on your stock certificate. If shares of stock are held in the name of two or more persons or in the name of husband and wife, either as joint tenants or otherwise, both or all of such persons should sign the above proxy card. If shares of stock are held by a corporation, the proxy card should be executed by the president or vice president and the secretary or assistant secretary. Executors or administrators or other fiduciaries who execute the above proxy card for a deceased stockholder should give their full title. Please date the proxy card.
^ FOLD AND DETACH HERE ^